Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning
- 22 February 2018
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 65 (6), e27010
- https://doi.org/10.1002/pbc.27010
Abstract
Infantile malignant osteopetrosis (IMO) is an autosomal recessive condition characterized by defective osteoclast activity, with hematopoietic bone marrow transplant being the only available cure. Over the past several years, new conditioning regimes and donor options have emerged, thus extending the possibility of cure to a greater number of patients and improving the outcomes of bone marrow transplant. Here we detail the outcomes of bone marrow transplant in a cohort of 31 patients treated with a combination of fludarabine, treosulphan, thiotepa, and antithymocyte globulin. Thirty-one patients with IMO who underwent hematopoietic stem cell transplantation with fludarabine, treosulphan, thiotepa, and antithymocyte globulin at our center from 2012 to 2017 are retrospectively reviewed in this study. Twenty-six patients were transplanted from 10/10 matched donors (13 from siblings, 11 from unrelated, and two from extended family donors), four from 9/10 matched unrelated donors, and one from a 9/10 matched family donor. Overall survival was 100% with a median follow-up of 363 days (range 74–1891). There were 12 cases of acute graft versus host disease (GvHD) (38.7%), no cases of veno-occlusive disease, and eight cases of hypercalcemia (25.8%). Almost 80% of patients suffered viral reactivations with two cases of Epstein–Barr-virus-driven post-transplant lymphoproliferative disease. All cases of GvHD and viral reactivation were successfully treated. We conclude that transplantation in children with IMO using fludarabine, treosulphan, thiotepa, and antithymocyte globulin is safe and effective and should be performed as early as possible following diagnosis, prior to the development of severe disease sequelae.Keywords
This publication has 22 references indexed in Scilit:
- Diseases Affecting Bone Quality: Beyond OsteoporosisClinical Orthopaedics and Related Research, 2011
- Reduced Intensity Transplantation for Primary Immunodeficiency DisordersPediatric Reports, 2011
- A single‐center experience in 20 patients with infantile malignant osteopetrosisAmerican Journal of Hematology, 2009
- OsteopetrosisOrphanet Journal of Rare Diseases, 2009
- Genetic analysis of autosomal recessive osteopetrosis in Chuvashiya: the unique splice site mutation in TCIRG1 gene spread by the founder effectEuropean Journal of Human Genetics, 2009
- Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimenBone Marrow Transplantation, 2006
- Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotideBone Marrow Transplantation, 2006
- Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT reportBone Marrow Transplantation, 2003
- Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplant.JCI Insight, 1996
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974